Mandate

Vinge advises Irisity in connection with a directed new share issue

November 14, 2019 Capital Markets and Public M&A

Vinge is advising Irisity in connection with a directed new share issue of 4,094,000 shares whereby Irisity acquires approximately SEK 35 million.

A subscription price of SEK 8.55 has been determined through an accelerated book building procedure and constitutes a discount of approximately 7.1 per cent in comparison with the closing price of Irisity shares on Nasdaq First North on 13 November 2019. The issue proceeds, which are expected to be sufficient for Irisity to acquire a positive cashflow, are intended to strengthen the company’s financial stability and also be used to expand the organisation within the fields of research, development, marketing, sales and service. The resolution adopted by the board of directors concerning the new share issue is conditional upon the approval thereof at an extraordinary general meeting.

 

Vinge’s team mainly consisted of Anders StridJohanna Hamrefält and Lina André.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026